Abdm
It is a surprised for a well research poster such as yourself to think that ANP is giving away the patents/licenses of ATL1102 for free.
Obviously placed no value in the cost needed for clinical trials, which is the main activity/concern as a Biotech before the exit point to a big Pharma in Phase III.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.786M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.9¢ | $5.433K | 609.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 7926679 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1706234 | 4 |
View Market Depth
| Last trade - 11.56am 18/07/2025 (20 minute delay) ? |
| PER (ASX) Chart |